Login / Signup

Hyperlipidemia patients with long-term statin treatment are associated with a reduced risk of progression of benign prostatic enlargement.

Hung-Jen ShihPei-Shan TsaiYu-Ching WenMing-Chang KaoYen-Chun FanChun-Jen Huang
Published in: The aging male : the official journal of the International Society for the Study of the Aging Male (2018)
Hyperlipidemia patients with long-term statin treatment (more than 365 days) are associated with a reduced risk of BPE progression.
Keyphrases
  • cardiovascular disease
  • coronary artery disease
  • high fat diet
  • prostate cancer
  • skeletal muscle
  • radical prostatectomy